To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Pittsburgh's biotech sector ...
Recursion Pharmaceuticals crashed 90% but JPMorgan upgraded with $11 target implying near tripling. Eli Lilly partnered with Nvidia on a $1B AI drug discovery collaboration using Vera Rubin chips.
Krystal Biotech pioneered the first topical gene therapy. ARS Pharmaceuticals introduced the first needle-free therapy to treat anaphylaxis. Both therapies have blockbuster potential. In 2023, Krystal ...
HONG KONG/SHANGHAI, Feb 13 (Reuters) - Global drugmakers are stepping up their search for China‑developed experimental medicines as they cut costs ahead of patent expirations, with industry analysts ...
EyePoint (EYPT), Janux (JANX), Kyverna (KYTX), and Viking (VKTX) have analyst targets implying 179% to 384% upside. Janux and Kyverna hold the highest upside projections at 384% and 308% respectively, ...
‘My scientific career is essentially over.’ A brain drain imperils Massachusetts’ biomedical future.
A prominent cancer scientist is uprooting his Harvard University lab of two decades and moving it to Texas. A laid-off expert on aging abandoned academia for a more secure municipal research job in ...
Fresh off a whirlwind week of travel between Dallas and New York, former Tennis player and influencer Ayan Broomfield stepped out for the Tory Burch FW26 show during New York Fashion Week. The athlete ...
Registration Questions? **Please note we have pricing tiers based on ticket availability. Ticket prices will increase once we sell out of the current pricing tier. We cannot redeem a lower price once ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results